Table of Contents Author Guidelines Submit a Manuscript
Current Gerontology and Geriatrics Research
Volume 2011, Article ID 673012, 5 pages
http://dx.doi.org/10.1155/2011/673012
Clinical Study

Verbal Episodic Memory and Endogenous Estradiol: An Association in Patients with Mild Cognitive Impairment and Alzheimer's Disease

1Memory Clinic and Department of Neurology, University of Ulm, 89075 Ulm, Germany
2Department of Neurology, Otto-von-Guericke University of Magdeburg, 39120 Magdeburg, Germany
3Psychiatry II Department of Gerontopsychiatry, University of Ulm, 89321 Ulm, Germany

Received 3 May 2011; Revised 5 September 2011; Accepted 19 September 2011

Academic Editor: Fulvio Lauretani

Copyright © 2011 D. M. Bittner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. McKhann, D. Drachman, M. Folstein et al., “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease,” Neurology, vol. 34, no. 7, pp. 939–944, 1984. View at Google Scholar · View at Scopus
  2. R. J. Perry and J. R. Hodges, “Fate of patients with questionable (very mild) Alzheimer's disease: longitudinal profiles of individual subjects' decline,” Dementia and Geriatric Cognitive Disorders, vol. 11, no. 6, pp. 342–349, 2000. View at Google Scholar · View at Scopus
  3. N. R. Cutler, J. V. Haxby, R. Duara et al., “Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease,” Neurology, vol. 35, no. 11, pp. 1556–1561, 1985. View at Google Scholar
  4. F. J. Bonte, E. D. Ross, H. H. Chehabi, and M. D. Devous, “SPECT study of regional cerebral blood flow in Alzheimer disease,” Journal of Computer Assisted Tomography, vol. 10, no. 4, pp. 579–583, 1986. View at Google Scholar · View at Scopus
  5. K. A. Johnson, S. T. Mueller, T. M. Walshe, R. J. English, and B. L. Holman, “Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123,” Archives of Neurology, vol. 44, no. 2, pp. 165–168, 1987. View at Google Scholar
  6. D. H. S. Silverman, G. W. Small, C. Y. Chang et al., “Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome,” Journal of the American Medical Association, vol. 286, no. 17, pp. 2120–2127, 2001. View at Google Scholar · View at Scopus
  7. N. Andreasen and K. Blennow, “β-Amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease,” Peptides, vol. 23, no. 7, pp. 1205–1214, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Andreasen, L. Minthon, P. Davidsson et al., “Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice,” Archives of Neurology, vol. 58, no. 3, pp. 373–379, 2001. View at Google Scholar · View at Scopus
  9. S. Rasmuson, R. Andrew, B. Näsman, J. R. Seckl, B. R. Walker, and T. Olsson, “Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease,” Biological Psychiatry, vol. 49, no. 6, pp. 547–552, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. N. C. Inestrosa, M. P. Marzolo, and A. B. Bonnefont, “Cellular and molecular basis of estrogen's neuroprotection: potential relevance for Alzheimer's disease,” Molecular Neurobiology, vol. 17, no. 1–3, pp. 73–86, 1998. View at Google Scholar · View at Scopus
  11. R. Marin, B. Guerra, J. G. Hernández-Jiménez et al., “Estradiol prevents amyloid-β peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptor,” Neuroscience, vol. 121, no. 4, pp. 917–926, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Xu, S. Chen, S. H. Ahmed et al., “Amyloid-beta peptides are cytotoxic to oligodendrocytes,” Journal of Neuroscience, vol. 21, no. 1, p. RC118, 2001. View at Google Scholar · View at Scopus
  13. C. Kawas, S. Resnick, A. Morrison et al., “A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging,” Neurology, vol. 48, no. 6, pp. 1517–1521, 1997. View at Google Scholar · View at Scopus
  14. A. Paganini-Hill and V. W. Henderson, “Estrogen replacement therapy and risk of Alzheimer disease,” Archives of Internal Medicine, vol. 156, no. 19, pp. 2213–2217, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. R. F. Zec and M. A. Trivedi, “The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review,” Neuropsychology Review, vol. 12, no. 2, pp. 65–109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Shumaker, C. Legault, S. R. Rapp et al., “Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women,” Journal of the American Medical Association, vol. 289, no. 20, pp. 2651–2662, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. S. Asthana, L. D. Baker, S. Craft et al., “High-dose estradiol improves cognition for women with AD results of a randomized study,” Neurology, vol. 57, no. 4, pp. 605–612, 2001. View at Google Scholar · View at Scopus
  18. V. Senanarong, S. Vannasaeng, N. Poungvarin et al., “Endogenous estradiol in elderly individuals: cognitive and noncognitive associations,” Archives of Neurology, vol. 59, no. 3, pp. 385–389, 2002. View at Google Scholar · View at Scopus
  19. C. J. Cunningham, M. Sinnott, A. Denihan et al., “Endogenous sex hormone levels in postmenopausal women with Alzheimer's disease,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 3, pp. 1099–1103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. J. J. Manly, C. A. Merchant, D. M. Jacobs et al., “Endogenous estrogen levels and Alzheimer's disease among postmenopausal women,” Neurology, vol. 54, no. 4, pp. 833–837, 2000. View at Google Scholar · View at Scopus
  21. H. A. Feldman, C. Longcope, C. A. Derby et al., “Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 589–598, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Gray, H. A. Feldman, J. B. McKinlay, and C. Longcope, “Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study,” Journal of Clinical Endocrinology and Metabolism, vol. 73, no. 5, pp. 1016–1025, 1991. View at Google Scholar · View at Scopus
  23. R. C. Petersen, G. E. Smith, S. C. Waring, R. J. Ivnik, E. G. Tangalos, and E. Kokmen, “Mild cognitive impairment: clinical characterization and outcome,” Archives of Neurology, vol. 56, no. 3, pp. 303–308, 1999. View at Google Scholar · View at Scopus
  24. M. F. Folstein, S. E. Folstein, and P. R. McHugh, ““Mini mental state”. A practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar · View at Scopus
  25. D. L. Delis, J. Kramer, E. Kaplan, and D. Ober, The California Verbal Learning Test, Psychological Corporation, San Antonio, Tex, USA, 1986.
  26. E. K. Hoskin, M. X. Tang, J. J. Manly, and R. Mayeux, “Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease,” Neurobiology of Aging, vol. 25, no. 2, pp. 141–147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. C. E. I. Lebrun, Y. T. van der Schouw, F. H. de Jong, H. A. P. Pols, D. E. Grobbee, and S. W. J. Lamberts, “Endogenous oestrogens are related to cognition in healthy elderly women,” Clinical Endocrinology, vol. 63, no. 1, pp. 50–55, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. Paganini-Hill and V. W. Henderson, “Estrogen deficiency and risk of Alzheimer's disease in women,” American Journal of Epidemiology, vol. 140, no. 3, pp. 256–261, 1994. View at Google Scholar
  29. S. M. Phillips and B. B. Sherwin, “Effects of estrogen on memory function in surgically menopausal women,” Psychoneuroendocrinology, vol. 17, no. 5, pp. 485–495, 1992. View at Publisher · View at Google Scholar
  30. M. X. Tang, D. Jacobs, Y. Stern et al., “Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease,” The Lancet, vol. 348, no. 9025, pp. 429–432, 1996. View at Publisher · View at Google Scholar
  31. M. C. Tierney, P. Oh, R. Moineddin et al., “A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women,” Psychoneuroendocrinology, vol. 34, no. 7, pp. 1065–1074, 2009. View at Publisher · View at Google Scholar · View at PubMed
  32. A. Morrison, S. Resnick, M. Corrado, A. Zonderman, and C. Kawas, “A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease in the Baltimore Longitudinal Study of Aging,” Neurology, vol. 46, supplement 2, pp. A435–A436, 1996. View at Google Scholar
  33. J. Ryan, I. Carrière, J. Scali et al., “Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C study,” Neurology, vol. 73, no. 21, pp. 1729–1737, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. H. Honjo, Y. Ogino, K. Tanaka et al., “An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: a placebo-controlled, double-blind study,” Journal of Japanese Men Society, vol. 1, pp. 167–171, 1993. View at Google Scholar
  35. B. B. Sherwin, “Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women,” Psychoneuroendocrinology, vol. 13, no. 4, pp. 345–357, 1988. View at Google Scholar · View at Scopus
  36. B. B. Sherwin and J. McGill, “Estrogen and cognitive functioning in women,” Endocrine Reviews, vol. 24, no. 2, pp. 133–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. C. D. Toran-Allerand, R. C. Miranda, W. D. L. Bentham et al., “Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 10, pp. 4668–4672, 1992. View at Publisher · View at Google Scholar
  38. F. Liu, M. Day, L. C. Muñiz et al., “Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory,” Nature Neuroscience, vol. 11, no. 3, pp. 334–343, 2008. View at Publisher · View at Google Scholar · View at PubMed
  39. B. S. McEwen and C. S. Woolley, “Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain,” Experimental Gerontology, vol. 29, no. 3-4, pp. 431–436, 1994. View at Publisher · View at Google Scholar
  40. D. Applebaum-Bowden, P. McLean, A. Steinmetz et al., “Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women,” Journal of Lipid Research, vol. 30, no. 12, pp. 1895–1906, 1989. View at Google Scholar
  41. B. B. Sherwin, H. Chertkow, H. Schipper, and Z. Nasreddine, “A randomized controlled trial of estrogen treatment in men with mild cognitive impairment,” Neurobiology of Aging, vol. 32, no. 10, pp. 1808–1817, 2011. View at Publisher · View at Google Scholar · View at PubMed